Roche Makes $5.7B Bid for Illumina

Keith Moore, MKM Partners, discusses how to play Roche's hostile bid for gene sequencer, Illumin, saying ILMN is likely to fight the takeover. Also an update on SanDisk's earnings, with the Fast Money crew.

CNBC | January 25, 2012

Tags:. .sandisk. .mkm. .hostile. .illumin. .takeover